Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR021618 for postoperative moderate-to-severe abdominal surgery pain
CTR20200824Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HR021618 in postoperative pain, sponsored by Hengrui Therapeutics. Started May 2020; status: completed.
02
Drugs
HR021618
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20200824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200824.